Literature DB >> 12586821

Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.

Shengwei Yu1, Stefania Girotto, Chiuhong Lee, Richard S Magliozzo.   

Abstract

Catalase-peroxidase (KatG) from Mycobacterium tuberculosis is responsible for the activation of the antitubercular drug isonicotinic acid hydrazide (INH) and is important for survival of M. tuberculosis in macrophages. Characterization of the structure and catalytic mechanism of KatG is being pursued to provide insights into drug (INH) resistance in M. tuberculosis. Site-directed mutagenesis was used to prepare the INH-resistant mutant KatG[S315T], and the overexpressed enzyme was characterized and compared with wild-type KatG. KatG[S315T] exhibits a reduced tendency to form six-coordinate heme, because of coordination of water to iron during purification and storage, and also forms a highly unstable Compound III (oxyferrous enzyme). Catalase activity and peroxidase activity measured using t-butylhydroperoxide and o-dianisidine were moderately reduced in the mutant compared with wild-type KatG. Stopped-flow spectrophotometric experiments revealed a rate of Compound I formation similar to wild-type KatG using peroxyacetic acid to initiate the catalytic cycle, but no Compound I was detected when bulkier peroxides (chloroperoxybenzoic acid, t-butylhydroperoxide) were used. The affinity of resting (ferric) KatG[S315T] for INH, measured using isothermal titration calorimetry, was greatly reduced compared with wild-type KatG, as were rates of reaction of Compound I with the drug. These observations reveal that although KatG[S315T] maintains reasonably good steady state catalytic rates, poor binding of the drug to the enzyme limits drug activation and brings about INH resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586821     DOI: 10.1074/jbc.M300326200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Isoniazid metal complex reactivity and insights for a novel anti-tuberculosis drug design.

Authors:  Eduardo Henrique Silva Sousa; Luiz Augusto Basso; Diógenes S Santos; Izaura Cirino Nogueira Diógenes; Elisane Longhinotti; Luiz Gonzaga de França Lopes; Icaro de Sousa Moreira
Journal:  J Biol Inorg Chem       Date:  2011-09-28       Impact factor: 3.358

2.  Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.

Authors:  Tali H Reingewertz; Tom Meyer; Fiona McIntosh; Jaryd Sullivan; Michal Meir; Yung-Fu Chang; Marcel A Behr; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

3.  Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis.

Authors:  Rituraj Purohit; Vidya Rajendran; Rao Sethumadhavan
Journal:  J Mol Model       Date:  2010-07-01       Impact factor: 1.810

4.  Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.

Authors:  L Mo; W Zhang; J Wang; X H Weng; S Chen; L Y Shao; M Y Pang; Z W Chen
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

5.  Single-site mutations on the catalase-peroxidase from Sinorhizobium meliloti: role of the distal Gly and the three amino acids of the putative intrinsic cofactor.

Authors:  Silvia Ardissone; Enzo Laurenti; Pierre Frendo; Elena M Ghibaudi; Alain Puppo
Journal:  J Biol Inorg Chem       Date:  2005-11-08       Impact factor: 3.358

6.  Modeling the structural origins of drug resistance to isoniazid via key mutations in Mycobacterium tuberculosis catalase-peroxidase, KatG.

Authors:  Matthew W Marney; Robert P Metzger; David Hecht; Faramarz Valafar
Journal:  Tuberculosis (Edinb)       Date:  2017-11-22       Impact factor: 3.131

7.  Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia.

Authors:  N Shubladze; N Tadumadze; N Bablishvili
Journal:  Int J Mycobacteriol       Date:  2013-06-01

Review 8.  Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.

Authors:  Saifur R Khan; Yousef Manialawy; Arno G Siraki
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

9.  Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.

Authors:  Christine E Cade; Adrienne C Dlouhy; Katalin F Medzihradszky; Saida Patricia Salas-Castillo; Reza A Ghiladi
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

10.  An oxyferrous heme/protein-based radical intermediate is catalytically competent in the catalase reaction of Mycobacterium tuberculosis catalase-peroxidase (KatG).

Authors:  Javier Suarez; Kalina Ranguelova; Andrzej A Jarzecki; Julia Manzerova; Vladimir Krymov; Xiangbo Zhao; Shengwei Yu; Leonid Metlitsky; Gary J Gerfen; Richard S Magliozzo
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.